On the occasion of the 10th international french-speaking conference of #AFRAVIH2020, Charles Gore, the Medicines Patent Pool (MPP)’s Executive Director, discusses MPP’s progress on access to new direct-acting antiretrovirals for treating hepatitis C virus, with a focus on Western Africa.

More information on MPP’s impact on hepatitis C

Go to our interactive map to know treatments availability by region and country.